ARQT
Arcutis Biotherapeutics
$27.84
+$0.49 (+1.79%)Jul 27, 2026
Key metrics
The numbers that frame ARQT today
- Market cap
- $3.48B
- P/E (TTM)
- -1,465.6
- EV / FCF
- 132.3
- Gross margin
- 90.9%
- EV / Sales
- 8.6
- ROIC
- 3.7%
- Div yield
- 0%
- Debt / equity
- 0.6
- 52wk Low
- $13.70
- 52wk High
- $31.77
Growth
Revenue and earnings trend for ARQT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ARQT
Is Arcutis Biotherapeutics a good buy?
Yes. Arcutis Biotherapeutics has mixed quality and excellent momentum. Taken together, the setup leans positive. Growth looks strong, which supports the long-term business case. We think Arcutis Biotherapeutics is selling at a high price, which cuts against the buy case.
What is the market capitalization of ARQT?
Arcutis Biotherapeutics's market capitalization is $3.48B.
What is the P/E ratio for ARQT stock?
Arcutis Biotherapeutics's current P/E ratio is -1,465.6.
What is the 52-week high for ARQT stock?
The 52-week high for Arcutis Biotherapeutics is $31.77. The current close of $27.84 is 12.4% below that high.
What is the 52-week low for ARQT stock?
The 52-week low for Arcutis Biotherapeutics is $13.70. The current close of $27.84 is 103.3% above that low.
Does ARQT stock pay dividends?
Arcutis Biotherapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ARQT?
Arcutis Biotherapeutics's Debt / Equity ratio is 0.61.